Personalized Nutrition Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

The personalized nutrition market delivers customized dietary and supplement regimens based on individual genetic, metabolic, and lifestyle data. It has grown from $15.79 billion in 2025 to $18.064 billion in 2026 and is on track to reach over $30 billion by 2030, reflecting strong adoption across health-conscious demographics and chronic disease management segments.

• •Market value increased from $15.79B in 2025 to $18.064B in 2026, with a projected CAGR of 14.4% through 2030.
• •Products include DNA- and microbiome-based supplements, AI-recommended meal plans, and biomarker-guided formulations.
• •Growth is fueled by consumer shift from generic supplements to science-backed, individualized nutrition solutions.

Advancements in affordable genomic and microbiome testing have enabled scalable personalization, while rising chronic disease prevalence and consumer interest in preventive health are accelerating adoption. Digital health platforms and wearable integration further enhance data collection and real-time dietary adjustments.

• •Declining costs of genetic and gut microbiome analysis make personalized insights accessible to broader populations.
• •Increasing prevalence of metabolic disorders like diabetes and obesity drives demand for targeted nutritional interventions.
• •Integration with fitness trackers and health apps enables continuous feedback loops for dynamic nutrition planning.

The market is segmented by product form, application, and product type, with tablets and capsules dominating delivery methods. North America leads in adoption due to high healthcare spending and tech infrastructure, while Europe and Asia-Pacific are growing rapidly due to regulatory support and rising middle-class health awareness.

• •Tablets and capsules account for the largest share of product forms, followed by powders and liquids.
• •Disease-based supplements (e.g., for diabetes, cardiovascular health) are growing faster than standard supplements.
• •North America holds the largest market share, with Asia-Pacific projected to be the fastest-growing region through 2030.

Who are the notable companies in the industry?

The market is moderately fragmented, with a mix of specialized startups and diversified health conglomerates entering through acquisitions or internal R&D. Production relies primarily on precision formulation technologies using biological data inputs, with supply chains concentrated in North America and Western Europe due to regulatory expertise and advanced manufacturing capabilities.

• •Market structure is moderately fragmented, with no single player dominating; competition includes both niche innovators and large health companies expanding into personalization.
• •Producers are primarily specialty-focused, leveraging proprietary algorithms and biological data platforms rather than mass-market supplement models.
• •Core technology routes involve genomic sequencing, metabolomic profiling, and AI-driven formulation engines, with manufacturing capacity concentrated in North America and Western Europe.

What are the recent trends and outlook?

The market is evolving toward next-generation personalization, incorporating epigenetics, real-time biomonitoring, and food-as-medicine approaches. Regulatory frameworks are adapting to ensure data privacy and clinical validity, while partnerships between nutrition brands, diagnostics firms, and digital health platforms are becoming standard.

• •Next-generation personalized nutrition, incorporating epigenetics and continuous biomarker tracking, is growing at 15-17% CAGR.
• •Regulatory bodies are developing guidelines for claims validation and data security in genetic-based nutrition products.
• •Strategic alliances between diagnostic labs, AI developers, and supplement manufacturers are accelerating product innovation and scalability.